Published 9 days ago • loading... • Updated 9 days ago
Dyadic International (Nasdaq: DYAI) Advances Next-Generation Biomanufacturing With Global Health Support to Help Turn AI-Designed DNA Into Life-Saving Products
JUPITER, Fla. Support from the Gates Foundation, CEPI and the European Vaccines Hub highlights Dyadic’s potential to accelerate vaccine, antibody and biologics development while improving manufacturing productivity, scalability and affordability Dyadic International, Inc. (Nasdaq: DYAI), a biotechnology company focused on developing scalable and cost-efficient protein production technologies, is advancing efforts to transform how vaccines, monoc…